Patients with radiographic axial spondylarthritis have an impaired dietary intake-a cross-sectional study with matched controls from northern Sweden.
Ankylosing spondylitis (D013167)
Axial spondyloarthritis (D000089183)
Diet (D004032)
Malnutrition (D044342)
Journal
Arthritis research & therapy
ISSN: 1478-6362
Titre abrégé: Arthritis Res Ther
Pays: England
ID NLM: 101154438
Informations de publication
Date de publication:
07 08 2023
07 08 2023
Historique:
received:
27
03
2023
accepted:
26
07
2023
medline:
9
8
2023
pubmed:
8
8
2023
entrez:
7
8
2023
Statut:
epublish
Résumé
Radiographic axial spondyloarthritis (r-axSpA) is one of the most common chronic inflammatory rheumatic diseases, affecting about 0.2% of the Swedish population. Adequate nutritional intake is essential for maintaining physiological functions. A poor diet increases the risk of developing conditions such as obesity, osteoporosis, and/or atherosclerosis. Diet quality is also theorized to affect systemic inflammation. Dietary habits in patients with r-axSpA are largely unknown. The aims of this study were to assess dietary nutrient intake in r-axSpA patients and examine whether it differs compared to persons without r-axSpA. r-axSpA patients (modified NY criteria) at the rheumatology clinic in Region Västerbotten, northern Sweden, were invited to take part in the Backbone study which investigates disease severity and comorbidities. In total, 155 patients were included. Nutritional intake was assessed by the semi-quantitative food frequency questionnaire MiniMeal-Q. Controls were collected from the Swedish CArdioPulmonary bioImage Study (n = 30,154), a study that invited participants 50-64 years of age by random selection from the Swedish population register. Out of the 155 r-axSpA patients, 81 were in the same age span. Four controls were identified for each patient, matched on age (± 1 year), sex, and geographic location. Data on dietary intake was available for 319 controls. Statistical comparisons of dietary intake between patients with r-axSpA and controls were done by exact conditional logistic regression analysis, adjusted for country of birth, educational level, single household, weight, smoking status, and energy intake. Patients had a comparatively significantly higher energy intake from carbohydrates, a lower fiber density, and a lower intake of marine omega-3 fatty acids. Furthermore, intake of vitamins D, E, and K as well as selenium, folate, calcium, magnesium, phosphorus, potassium, vitamin A, and β-carotene (a precursor of vitamin A and marker of vegetable and fruit intake) was significantly lower among patients compared to controls. Our results suggest that r-axSpA patients have an impaired dietary intake. Notably, intake was lower in several nutrients theorized to have anti-inflammatory properties (fiber density, marine-omega-3 fatty acids, vitamin D, and selenium). We further propose that nutrition screening might be incorporated into the management of r-axSpA patients.
Sections du résumé
BACKGROUND
Radiographic axial spondyloarthritis (r-axSpA) is one of the most common chronic inflammatory rheumatic diseases, affecting about 0.2% of the Swedish population. Adequate nutritional intake is essential for maintaining physiological functions. A poor diet increases the risk of developing conditions such as obesity, osteoporosis, and/or atherosclerosis. Diet quality is also theorized to affect systemic inflammation. Dietary habits in patients with r-axSpA are largely unknown. The aims of this study were to assess dietary nutrient intake in r-axSpA patients and examine whether it differs compared to persons without r-axSpA.
METHODS
r-axSpA patients (modified NY criteria) at the rheumatology clinic in Region Västerbotten, northern Sweden, were invited to take part in the Backbone study which investigates disease severity and comorbidities. In total, 155 patients were included. Nutritional intake was assessed by the semi-quantitative food frequency questionnaire MiniMeal-Q. Controls were collected from the Swedish CArdioPulmonary bioImage Study (n = 30,154), a study that invited participants 50-64 years of age by random selection from the Swedish population register. Out of the 155 r-axSpA patients, 81 were in the same age span. Four controls were identified for each patient, matched on age (± 1 year), sex, and geographic location. Data on dietary intake was available for 319 controls. Statistical comparisons of dietary intake between patients with r-axSpA and controls were done by exact conditional logistic regression analysis, adjusted for country of birth, educational level, single household, weight, smoking status, and energy intake.
RESULTS
Patients had a comparatively significantly higher energy intake from carbohydrates, a lower fiber density, and a lower intake of marine omega-3 fatty acids. Furthermore, intake of vitamins D, E, and K as well as selenium, folate, calcium, magnesium, phosphorus, potassium, vitamin A, and β-carotene (a precursor of vitamin A and marker of vegetable and fruit intake) was significantly lower among patients compared to controls.
CONCLUSIONS
Our results suggest that r-axSpA patients have an impaired dietary intake. Notably, intake was lower in several nutrients theorized to have anti-inflammatory properties (fiber density, marine-omega-3 fatty acids, vitamin D, and selenium). We further propose that nutrition screening might be incorporated into the management of r-axSpA patients.
Identifiants
pubmed: 37550771
doi: 10.1186/s13075-023-03126-3
pii: 10.1186/s13075-023-03126-3
pmc: PMC10405516
doi:
Substances chimiques
Selenium
H6241UJ22B
Vitamin A
11103-57-4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
142Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
J Med Internet Res. 2013 Jun 05;15(6):e109
pubmed: 23739995
Medicine (Baltimore). 2022 Nov 18;101(46):e31764
pubmed: 36401455
Clin Rheumatol. 1991 Dec;10(4):401-7
pubmed: 1802495
Scand J Rheumatol. 2006 Sep-Oct;35(5):359-62
pubmed: 17062435
Arch Public Health. 2017 Apr 10;75:17
pubmed: 28400959
Antioxid Redox Signal. 2018 Jan 1;28(1):78-84
pubmed: 28877589
Nutrients. 2022 Dec 14;14(24):
pubmed: 36558465
Ann Rheum Dis. 2023 Jan;82(1):19-34
pubmed: 36270658
J Nutr. 2019 Dec 1;149(12):2206-2218
pubmed: 31373368
Eur Rev Med Pharmacol Sci. 2009 May-Jun;13(3):233-4
pubmed: 19673175
J Health Psychol. 2019 Dec;24(14):2042-2059
pubmed: 28810493
Clin Chim Acta. 2019 Oct;497:189-196
pubmed: 31377126
J Rheumatol. 2021 Mar;48(3):352-360
pubmed: 32611672
Nutrition. 2018 Jan;45:114-124.e4
pubmed: 28965775
Clin Rheumatol. 1996 Jan;15 Suppl 1:62-66
pubmed: 8835506
Biochem Soc Trans. 2017 Oct 15;45(5):1105-1115
pubmed: 28900017
Nutrients. 2013 Jul 05;5(7):2502-21
pubmed: 23857223
J Nutr. 2016 Aug;146(8):1560-70
pubmed: 27358416
BMJ Open. 2020 Nov 20;10(11):e038715
pubmed: 33444189
Arthritis Res Ther. 2022 Jul 7;24(1):163
pubmed: 35794662
J Nutr. 2021 Dec 3;151(12):3856-3864
pubmed: 34587253
J Med Internet Res. 2014 Feb 21;16(2):e59
pubmed: 24565605
Nutrients. 2016 Jul 22;8(7):
pubmed: 27455317
BMJ Open. 2022 Apr 29;12(4):e057850
pubmed: 35487753
Nutrients. 2022 Nov 09;14(22):
pubmed: 36432416
Nutr J. 2021 Jan 23;20(1):9
pubmed: 33485336
J Rheumatol. 2010 Oct;37(10):2118-25
pubmed: 20716665
Arthritis Res Ther. 2018 Dec 27;20(1):284
pubmed: 30587228
BMC Musculoskelet Disord. 2008 Jan 11;9:4
pubmed: 18190710
Cochrane Database Syst Rev. 2008 Jan 23;(1):CD002822
pubmed: 18254008
J Intern Med. 2015 Dec;278(6):645-59
pubmed: 26096600
Ann Rheum Dis. 1994 Jul;53(7):481-2
pubmed: 7944628
J Rheumatol. 2012 Feb;39(2):327-33
pubmed: 22174215
Hum Nutr Clin Nutr. 1985;39 Suppl 1:5-41
pubmed: 4044297
RMD Open. 2022 Jun;8(2):
pubmed: 35654458
Arthritis Rheum. 1984 Apr;27(4):361-8
pubmed: 6231933
Curr Rheumatol Rev. 2019;15(2):123-134
pubmed: 30324883
Nutrients. 2018 Sep 01;10(9):
pubmed: 30200430
Arthritis Res Ther. 2019 Nov 27;21(1):248
pubmed: 31771630
Rheumatology (Oxford). 2014 Apr;53(4):650-7
pubmed: 24324212
BMJ. 2022 Jan 26;376:e066452
pubmed: 35082139
J Nutr Sci. 2020 Aug 27;9:e37
pubmed: 32983422
Nat Rev Gastroenterol Hepatol. 2021 Dec;18(12):885-902
pubmed: 34580480
Clin Rheumatol. 2014 Jan;33(1):111-7
pubmed: 24135890
Clin Rheumatol. 2022 Feb;41(2):491-498
pubmed: 34581892
J Pain. 2008 Aug;9(8):722-31
pubmed: 18468955
Ann Rheum Dis. 2005 Jan;64(1):127-9
pubmed: 15051621
PLoS One. 2014 Dec 04;9(12):e114350
pubmed: 25474157